Alaunos Therapeutics Inc (TCRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Sales | 1,919 | 1,869 | 272 | 272 | 340 |
| Gross Profit | 1,919 | 1,869 | 272 | 272 | 340 |
| Operating Expenses | 11,401 | 20,035 | 14,497 | 78,499 | 10,936 |
| Operating Income | -9,482 | -18,166 | -14,225 | -78,227 | -10,596 |
| Other Income | 6 | -4 | 14 | -4 | 195 |
| Pre-tax Income | -9,476 | -18,170 | -14,211 | -78,231 | -10,401 |
| Net Income Continuous | -9,476 | -18,170 | -14,211 | -78,231 | -10,401 |
| Net Income | $-9,476 | $-18,170 | $-14,211 | $-78,231 | $-10,401 |
| EPS Basic Total Ops | -3.00 | -20.99 | -16.49 | -103.45 | -13.49 |
| EPS Basic Continuous Ops | -2.55 | -21.00 | -16.59 | -103.42 | -15.17 |
| EPS Diluted Total Ops | -3.00 | -20.99 | -16.49 | -103.45 | -13.49 |
| EPS Diluted Continuous Ops | -2.55 | -21.00 | -16.59 | -103.42 | -15.17 |
| EBITDA(a) | $-9,420 | $-18,107 | $-14,111 | $-78,105 | $-10,473 |